WuXi PharmaTech takesover clinical research services companies
Both the companies offer services in regulatory affairs, Phase I-IV clinical trial management, and clinical trial site management in China. As part of the acquisition, MedKey/Jiecheng will increase
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.